• ISNI-International Society for Neurochemistry

    26th ISN-ESN Biennial Meeting
    August 20-24, 2017 in Paris, France

    Read more ...  
  • #ASNI2017

    2nd ASNI Course

    October 3-6, 2017 - Charlottesville (VA), USA

    Read more ...  
  • Regeneration

    November 16-18, 2017, Milan Italy

    Read more ...  
  • Postdoctoral Research Fellow in Australia

    Apply for a position as a Postdoctoral Research Fellow at the University of Queensland in Brisbane, Australia. 

    Read more ...  
  • AAT-AD/PD 2018

    15 - 18 March in Turin, Italy

    Read more ...  
  • CUBANNI 2017 - report

    CUBANNI 2017

    Read more ...  
  • ESOC 2018 - 4th European Stroke Organisation Conference

    ESOC 2018
    The 4th European STroke Organisation Conference

    16 - 18 May, 2018
    Gothenburg, Sweden

    Read more ...  

Bar-Or

 

Presidential Endowed Professor
Department of Neurology
Director, Centre for Neuroinflammation and Experimental Neurotherapeutics
Perelman School of Medicine
University of Pennsylvania (UPenn)

This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Dr. Bar-Or, a neurologist and neuroimmunologist, was Professor in the Department of Neurology and Neurosurgery, and Associate Director (Clinical and Translational Research) of the Montreal Neurological Institute and Hospital, McGill University, prior to taking on position of Presidential Endowed Chair at the University of Pennsylvania (UPenn/CHOP) where is founder and Director of the Centre for Neuroinflammation and Experimental Neurotherapeutics. His clinical focus is Multiple Sclerosis (MS) and related disorders in both adults and children, and he runs a cellular and molecular Neuroimmunology lab that studies basic principles of immune regulation and immune-neural interaction, in the context of inflammation, injury and repair of the human central nervous system (CNS). Research themes are directed at understanding principles of immune-regulation, elucidation of effector and regulatory mechanisms of distinct immune cell (principally T cell, B cell, and myelid cell) subsets in CNS inflammatory disease; immune reconstitution, neuroimmune interactions and mode of action of emerging therapies. He is past President of the Canadian Network of MS Clinics (CNMSC) and past member of the Board of Directors of the Federation of Clinical Immunology Societies (FOCIS) where he continues as a member of the Education Committee. He also serves on the Board of Directors of the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) and on the Steering Committee of the Immune Tolerance Network (ITN).

Joomla Template by Joomla51.com

This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the cookie policy. By closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies. To find out more about the cookies we use and how to delete them, see our Cookie policy